WallStreetZenWallStreetZen

NASDAQ: RPTX
Repare Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

RPTX past revenue growth

How has RPTX's revenue growth performed historically?
Company
-61.21%
Industry
148.4%
Market
16.96%
RPTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RPTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

RPTX earnings and revenue history

Current Revenue
$51.1M
Current Earnings
-$93.8M
Current Profit Margin
-183.4%

RPTX Return on Equity

Current Company
-39.8%
Current Industry
-63.5%
Current Market
188%
RPTX's Return on Equity (-39.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RPTX announces earnings.

RPTX Return on Assets

Current Company
-31.8%
Current Industry
2.9%
RPTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RPTX Return on Capital Employed

Current Company
-48.03%
Current Industry
19.5%
RPTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RPTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RPTX$51.13M-$99.03M-$93.80M+722.89%N/A
CLLS$24.41M-$27.35M-$85.01M-0.84%N/A
ANVS$0.00-$56.20M-$56.20MN/AN/A
SYRS$9.94M-$157.12M-$164.57M+37.12%N/A
ZURA$0.00-$60.36M-$69.24MN/AN/A
View Top Biotech Stocks

RPTX earnings dates

Next earnings date
May 7, 2024

Repare Therapeutics Earnings & Revenue FAQ

What were RPTX's earnings last quarter?

On Invalid Date, Repare Therapeutics (NASDAQ: RPTX) reported Q4 2023 earnings per share (EPS) of -$0.67, up 10.67% year over year. Total Repare Therapeutics earnings for the quarter were -$28.03 million. In the same quarter last year, Repare Therapeutics's earnings per share (EPS) was -$0.75.

If you're new to stock investing, here's how to buy Repare Therapeutics stock.

What was RPTX's earnings growth in the past year?

As of Q2 2024, Repare Therapeutics's earnings has grown year over year. Repare Therapeutics's earnings in the past year totalled -$93.80 million.

What is RPTX's earnings date?

Repare Therapeutics's earnings date is Invalid Date. Add RPTX to your watchlist to be reminded of RPTX's next earnings announcement.

What was RPTX's revenue last quarter?

On Invalid Date, Repare Therapeutics (NASDAQ: RPTX) reported Q4 2023 revenue of $13.05 million up 28.31% year over year. In the same quarter last year, Repare Therapeutics's revenue was $18.20 million.

What was RPTX's revenue growth in the past year?

As of Q2 2024, Repare Therapeutics's revenue has grown -61.21% year over year. This is 209.62 percentage points lower than the US Biotechnology industry revenue growth rate of 148.4%. Repare Therapeutics's revenue in the past year totalled $51.13 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.